IWP
RANI icon

Icon Wealth Partners’s Rani Therapeutics RANI Stock Holding History

Icon Wealth Partners’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,757
Closed -$65.8K – 426
2023
Q1 		$65.8K Buy
+12,757
New +$76.7K 0.01% 416

Other funds holding RANI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ASGS
Alpha Square Group S New York $103M AUM 63.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Icon Wealth Partners's RANI Position: Q2 2023 in Review

Icon Wealth Partners sold out of Rani Therapeutics (RANI) in Q2 2023, closing a stake of 12,757 shares — an estimated $65.8K sold.

Icon Wealth Partners first reported a position in RANI in Q1 2023 and held it in 1 quarter. The position peaked at $65.8K in Q1 2023. 35 funds tracked by Wall St. Rank hold RANI as of Q2 2023.

  • Icon Wealth Partners reported no remaining Rani Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Icon Wealth Partners sold 12,757 Rani Therapeutics shares in Q2 2023, an estimated $65.8K.
  • Icon Wealth Partners first reported a position in Rani Therapeutics in Q1 2023 and held it in 1 quarter.
  • Icon Wealth Partners's Rani Therapeutics position peaked at $65.8K in Q1 2023.
  • 35 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2023.

Based on Icon Wealth Partners's 13F filing for Q2 2023, filed 3 Aug 2023.